Doubleview Gold Corp. V.DBG

Alternate Symbol(s): DBLVF

Metals & Mining Industrial Metals & Minerals

Doubleview Gold Corp. is a mineral exploration and development company based in Vancouver, British Columbia, Canada. The Company identifies, acquires and finances precious and base metal exploration projects in North America, particularly in British Columbia. It focuses on acquisition and exploration of quality gold, copper and silver properties and the application of advanced exploration methods. Its projects include Hat Property and Red Spring Copper-Silver-Gold Property. The Company owns a 100% interest in the Hat Property. The Hat Property consists of ten mineral claims totaling 5214 hectares and is 50 kilometers northwest of Telegraph Creek, British Columbia. The property is subject to a 2% Net Smelter Royalty. The Company owns a 90% interest in the Red Spring Copper-Silver-Gold Property, which consists of six mineral claims totaling 4,224.34 ha, located in the Omineca Mining District of British Columbia. The Red Springs Property is subject to a 2.5% Net Smelter Property.

TSXV:DBG - Post by User

Doubleview Gold Corp.

Bullboard Posts

Comment by SirHumpsAloton Oct 17, 2017 10:24pm

88 Views

Post# 26824375

RE:Tuesday, October 17... Farshad files insider trading report.

What did I tell ya

lifegoeson wrote:
Well, DBV has gotten a little softer since the run up last week, the sell orders have increased and the support is very thin, I guess the old saying was true, what goes up, must come down. Let`s hope this is temporary, I have been in this stock for so long, it is beginning to grow moss. It is beginning to feel like another cheap financing coming with more dilution. I see Farshad has filed an insider trading report (6.6 M common shares and 6.6 M warrants). But now DBV needs to raise capital or get in bed with someone else. Too bad the momentum and price support has all but vanished, I sure hope we don`t go back down to those lows again.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide